-
Product Insights
Net Present Value Model: DT-216
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model DT-216 Drug Details DT-216 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DT-216
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry DT-216 Drug Details DT-216 is under development for the treatment of Friedreich ataxia. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – M-5717
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry M-5717 Drug Details DDD-498 (DDD-107498, M-5717) is under development for the treatment and prevention...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – fusidic acid
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry fusidic acid Drug Details Fusidic acid is under development for the treatment of melioidosis,...
-
Thematic Analysis
Mergers and Acquisitions (M&A) in Automotive – Thematic Research
In this report, we look at mergers and acquisitions (M&A) activity in the automotive sector over the last five years. We also highlight potential future bid targets in the sector, who is likely to acquire them and why.